What is it about?
Graves' disease (GD) does not increase the risk of thyroid carcinoma. Preventing malignancy should not be the reason for introducing surgical treatment of GD.
Featured Image
Why is it important?
The argument has never ended about how autoimmune thyroid diseases such as Hashimoto thyroiditis and Graves' disease (GD) contribute to the thyroid malignancy. The current study denied the hypothesis of GD as a risk factor for thyroid cancer by systematically collecting the available evidence. As a result, surgery should not be the reason for introducing surgical treatment of hyperthyroidism caused by GD.
Read the Original
This page is a summary of: Incidental thyroid carcinoma in surgery-treated hyperthyroid patients with Graves’ disease: a systematic review and meta-analysis of cohort studies, Cancer Management and Research, May 2018, Dove Medical Press,
DOI: 10.2147/cmar.s164210.
You can read the full text:
Contributors
The following have contributed to this page
